Loading…
Neuland Laboratories (NEULANDLAB)₹20,322+2.45%Pharmaceuticals
Neuland Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 52.5 against a peer median of 52.5, and ROCE of 26.0% against a peer median of 16.0%, and latest-quarter sales growth of 119.4% against a peer median of 27.9%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt | 32,910 | 81.0 | 8.0 | 6.1 | 0.45 | 0.0 | 3,364 | 199 | 26.0 | — | vs NEULANDLAB |
| Piramal Pharma | 32,767 | — | 3.0 | −3.9 | 0.70 | 0.0 | 8,842 | −327 | 27.9 | — | vs NEULANDLAB |
| Acutaas Chemicals | 31,798 | 72.5 | 32.0 | 24.0 | 0.02 | 0.1 | 1,340 | 356 | 42.7 | 71.0 | vs NEULANDLAB |
| Rubicon Research | 29,334 | 100.5 | 27.9 | 27.0 | 0.24 | 0.1 | 1,758 | 248 | 51.8 | 97.4 | vs NEULANDLAB |
| Neuland Laboratories | 26,012 | 52.5 | 26.0 | 21.2 | 0.16 | 0.2 | 2,017 | 364 | 119.4 | 956.7 | — |
| Alembic Pharmaceuticals | 20,041 | 28.9 | 13.1 | 13.5 | 0.25 | 1.2 | 7,321 | 671 | 25.6 | 11.5 | vs NEULANDLAB |
| Granules India | 19,820 | 29.6 | 16.0 | 13.8 | 0.30 | 0.2 | 5,343 | 593 | 22.3 | 59.3 | vs NEULANDLAB |
| Caplin Point Laboratories | 19,024 | 28.7 | 25.1 | 20.6 | 0.00 | 0.3 | 2,186 | 651 | 19.6 | 18.5 | vs NEULANDLAB |
| Onesource Specialty Pharma | 18,607 | — | 1.0 | −1.1 | 0.26 | 0.0 | 1,423 | −74 | 37.2 | 469.8 | vs NEULANDLAB |
| Shilpa Medicare | 18,303 | 61.6 | 10.9 | 9.4 | 0.25 | 0.1 | 1,533 | 243 | 45.1 | 114.9 | vs NEULANDLAB |
| Alivus Life Sciences | 18,135 | 30.0 | 24.9 | 19.0 | 0.02 | 0.3 | 2,562 | 566 | 6.3 | 31.1 | vs NEULANDLAB |
| Peer median | 20,041 | 52.5 | 16.0 | 13.8 | 0.25 | 0.1 | 2,186 | 356 | 27.9 | 71.0 |
Listed companies closest to Neuland Laboratories in Pharmaceuticals include Wockhardt, Piramal Pharma, Acutaas Chemicals, Rubicon Research, Alembic Pharmaceuticals, Granules India, Caplin Point Laboratories, Onesource Specialty Pharma.
Wockhardt, with a market cap of ₹32,910 Cr.
Neuland Laboratories trades at a P/E of 52.5; the median of its peer set is 52.5. A P/E above or below the median is a description, not a judgement on value.
Neuland Laboratories' return on capital employed is 26.0%, above the peer median of 16.0%.